Contact person

MVA’s calendar provides you with an overview of life science events and courses taking place in Medicon Valley. To stay updated on life science events and courses relevant for you and your colleagues, sign up for the bi-weekly newsletter MVA Update which lists all upcoming events and courses or subscribe to our Event RSS Feed.
Medicon Valley Alliance and Smithers would like to welcome you to a Good Morning Meeting 26th of November 2025. Design verification of combination pharmaceutical–medical devices is a critical step in ensuring regulatory compliance and product performance. This seminar on parenteral delivery systems explores best practices for developing robust strategies, aligning with regulatory requirements, and testing […]
Read moreMedicon Valley Alliance are pleased to invite you to an exclusive Good Morning Meeting hosted by Theradex Oncology and Simsen Diagnostics on 18h of November 2025. Designed specifically for pharmaceutical companies developing cancer therapies, this gathering offers an opportunity to gain actionable insights and explore innovative solutions for oncology clinical trials. Sharing the latest strategies […]
Read moreThe EU Competitiveness Compass Points to Medicon Valley The EU-Commission´s Draghi report explicitly highlights the bi-national Medicon Valley life science cluster as a potential life science innovation hub in a future European strategy for increasing European competitiveness within life science. What are our strongholds and unique selling points? How do we compare it with other […]
Read moreHow does the current political situation in the US affect early-stage innovation and commercialization in women’s health in the US and Europe? While women’s health is receiving more attention than ever and women’s health innovation has moved up on many agendas, women’s health researchers and startups are still facing great challenges when it comes to […]
Read moreMedicon Valley Alliance and Fios Genomics are pleased to invite you to a Good Morning Meeting on the 28th of October 2025 in Copenhagen. The road to new therapies is long, costly, and full of risk, but smarter use of data can change the odds. This session will explore how bioinformatics can drive success in […]
Read moreMedicon Valley Alliance and Capish are pleased to invite you to a Good Morning Meeting on the 22th of October 2025 in Copenhagen. In drug development, data quality is not just a box to tick — it is the backbone of regulatory success and patient safety. Poorly managed data can result in delayed approvals, critical […]
Read moreMedicon Valley Alliance and Svar Life Science would like to welcome you to a Good Morning Meeting 21st of October 2025. As regulatory expectations continue to evolve, the demand for potency assays that accurately reflect a drug’s mechanism of action has never been greater. Potency must be tightly controlled, recognized as a critical quality attribute […]
Read moreNow open for registration – Dent2Health 2025 We are delighted to announce that the 4th Annual Dent2Health Conference will be held on the 8th of October 2025. Dent2Health 2025 will highlight the connections between oral and systemic health from various perspectives, with a special focus on innovation. Confirmed speakers: • Tarunveer Singh Ahluwalia, Steno Diabetes […]
Read moreMedical device manufacturers must conduct biological (biocompatibility) evaluations for their medical devices to demonstrate biological safety not only when placing a medical device on the market, but throughout its complete lifecycle. Do you have a biological evaluation strategy for ensuring that your medical device product are safe for its intended use? Join us at the next […]
Read moreHow today’s innovators are tackling difficult cancer targets, refining models, and advancing ethical, effective drug development Learn more about our innovative oncology R&D, integrating scientific expertise with the 3Rs: Replace, Reduce, Refine of animal use in research for ethical responsibility. Featuring ChemPartner’s end-to-end platforms, case studies on KRAS G12C inhibitors and HER2 x TROP2 bispecific […]
Read moreMedicon Valley Alliance and ViruSure & Asahi Kasei would like to welcome you to a Boost Seminar on 24th of September 2025. Biosafety testing and virus filtration are critical pillars in safeguarding the quality and safety of biopharmaceutical products. This seminar will explore the evolving landscape of virus safety, with a focus on emerging technologies, […]
Read moreMedicon Valley Alliance and Project Medtech are pleased to invite you to two days of gaining experts insights, navigating regulatory pathways and understanding key market entry considerations – all designed to accelerate your journey into the U.S. healthcare ecosystem. Target Market Medical Device, Diagnostic, Wearables, Digital Health, Health IT, Software as a Medical Device Who […]
Read moreWomen’s cancers remain among the most challenging areas in oncology, marked by complex biology, limited early detection methods, and significant treatment gaps. This MVA Oncology Network meeting brings together experts from industry, academia, and clinical practice to explore how we can accelerate innovation and improve outcomes in these critical disease areas. Through a series of […]
Read moreMedicon Valley Alliance and Cencora PharmaLex are pleased to invite you to a Good Morning Meeting on the 18th of September 2025 in Copenhagen focusing on regulatory digital initiatives in the EU. Let’s discuss about regulatory digital initiatives in the EU such as ePI, eAF, IRIS and PMS. – Key challenges in pharmaceutical product lifecycle […]
Read moreAs Advanced Therapy Medicinal Products (ATMPs) transform modern medicine with their potential to treat, and even cure, a range of previously untreatable conditions, the need to create a solid foundation for their development, regulation, production, and clinical application has never been more pressing. The Medicon Valley region, with its cross-border strengths in life science research, […]
Read moreMedicon Valley Alliance and Catalent would like to welcome you to a Boost Seminar on 10th of September 2025. Join Catalent and Medicon Valley Alliance for an engaging half-day event focused on practical strategies to de-risk the development of new chemical modalities. We’ll cover the critical phases of small molecule development and provide insights into […]
Read moreMedicon Valley Alliance and BioAgilytix would like to welcome you to a Good Morning Meeting 9th of September 2025. In recent years, we have seen changes in regulations that affect bioanalytical strategies for drug development. Moving towards using leaner approaches, building in efficiencies, and simplifying overall strategies with the ultimate goal of reducing the time […]
Read moreThe skin microbiome has emerged as a key area of scientific interest, bridging dermatology, immunology, and microbiology. As our understanding of the skin’s microbial ecosystems grows, so does its potential to transform approaches to skincare, therapeutics, and personalized medicine. This MVA Microbiome Network meeting will shine a spotlight on the latest developments in skin microbiome […]
Read moreOur CEO Anette Steenberg will be participating in Almedalen. If you’re interested in connecting, don’t hesitate to get in touch. Anette Steenberg CEO, as@mva.org, +45 60 87 21 02 Engagements Nordic leadership in life science – collaboration for stronger competitiveness Date: Tuesday 24 June Time: 13:00 – 13:50 Place: Strandgatan 20 , Volare Europa befinner sig […]
Read moreMedicon Valley Alliance and TFS would like to welcome you to a Good Morning Meeting on the 18th of June 2025. Pharmacovigilance (PV) is a dynamic and essential part of ensuring post-marketing safety, especially as regulations evolve and new data types emerge. In this session, we’ll explore the critical steps involved in setting up a […]
Read moreRepresentatives from Medicon Valley Alliance will be attending Folkemødet on Bornholm. This year we will be engaged in several roundtable discussions that are not on the official agenda and lunch meetings. But if you’re interested in connecting, don’t hesitate to get in touch. Anette Steenberg CEO, as@mva.org, +45 60 87 21 02 David Munis Zepernick […]
Read moreMedicon Valley Alliance and Pharmaron would like to welcome you to a Good Morning Meeting 11th of June 2025. Imagine trying to discover and develop a medicine without knowledge of its metabolism and pharmacokinetic properties, or being able to contextualise drug behaviour across species using a range of computational, in vitro and in vivo approaches? […]
Read moreMedicon Valley Alliance and Smithers would like to welcome you to a Good Morning Meeting 4th of June 2025. The assessment of extractables and leachables (E&L) on pharmaceutical products, medical devices, delivery systems, and processing equipment have continued to evolve. This aligns with the expanding exposure of polymeric materials to patients, resulting in the path […]
Read moreThis biannual international educational forum has an emphasis on new directions, R&D and improvements of biologics, bioprocessing and ATMP with a focus on technical, rather than commercial, achievements. Topics may include analytical techniques, cell culturing and upstream processing, downstream processing, single-use systems, gene-therapy and regulatory issues. The event is mainly aimed at the following target […]
Read moreMedicon Valley Alliance and Servier are delighted to invite you to Servier’s 2025 R&D Partnering Day in The Nordics Servier is one of the leading French pharmaceutical companies. We have a long-standing commitment to external collaborations, particularly in oncology, neurology and technology platforms, to bring innovative medicines to patients. With our presence in Denmark through […]
Read more